Clinical Trials Related to Nab-paclitaxel

Related studies linked through entity extraction aliases.

Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer

Status: COMPLETED
Phase: PHASE1/PHASE2

Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer

Status: COMPLETED
Phase: PHASE2

Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer

Status: COMPLETED
Phase: PHASE3

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery

Status: COMPLETED
Phase: PHASE2

Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer

Status: COMPLETED
Phase: PHASE2

Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer

Status: COMPLETED
Phase: PHASE2

Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC

Status: TERMINATED
Phase: PHASE1/PHASE2

Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer

Status: TERMINATED
Phase: PHASE2

Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer

Status: COMPLETED
Phase: PHASE2

Neoadjuvant Treatment of Breast Cancer

Status: COMPLETED
Phase: PHASE2